VivoSim Labs (VIVS) Exchange Rate Effect (2016 - 2018)
VivoSim Labs (VIVS) posted quarterly Exchange Rate Effect of $13000.0 for Q1 2018, up 1400.0% year-over-year from $866.67 in Q1 2017, and up 750.0% quarter-over-quarter from -$2000.0 in Q4 2017.
VivoSim Labs (VIVS) Exchange Rate Effect (2016 - 2018) Analysis & Trends
VivoSim Labs' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at $13000.0 for Q1 2018.
- In Q1 2018, Exchange Rate Effect rose 1400.0% year-over-year to $13000.0; the TTM figure through Mar 2019 stood at $10000.0 (up 42.86% YoY), while the FY2018 annual figure was $11000.0, up 200.0% from the prior year.
- Exchange Rate Effect for Q1 2018 stood at $13000.0, up from -$2000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $13000.0 in Q1 2018, with the low at -$3000.0 in Q4 2016.
- The 3-year median for Exchange Rate Effect is -$1500.0 (2017), against an average of $1750.0.
- The sharpest annual moves came in 2017 and 2018: Exchange Rate Effect surged 33.33% in 2017, then jumped 1400.0% in 2018.
- VivoSim Labs' Exchange Rate Effect stood at -$3000.0 in 2016, then jumped by 33.33% to -$2000.0 in 2017, then surged by 750.0% to $13000.0 in 2018.
- Business Quant data shows VIVS's Exchange Rate Effect at $13000.0 in Q1 2018, -$2000.0 in Q4 2017, and -$1000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Dec 31, 2017 | -2,000.00 |
| Dec 31, 2017 | -2,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Dec 31, 2016 | -3,000.00 |
| Dec 31, 2016 | -3,000.00 |